Recognizing and Managing Cutaneous Adverse Events from Cancer Therapies

Learn to identify and effectively manage skin-related side effects of cancer therapies for better patient outcomes.

IntroductionAs the landscape of cancer treatment evolves, dermatologists are increasingly encountering cutaneous adverse events (CAEs) associated with various therapies. These skin-related side effects can significantly impact the quality of life for patients undergoing cancer treatment, making it essential for healthcare professionals to recognize and manage them effectively.Types of Cutaneous Adverse EventsCAEs can manifest in numerous forms, depending on the type of cancer therapy administered. Below are some common CAEs:Targeted therapies: Patients receiving targeted therapies, such as tyrosine kinase inhibitors (TKIs) and monoclonal antibodies, may develop rashes, pruritus, and dry skin. For instance, the use of EGFR inhibitors like erlotinib is commonly linked to acneiform eruptions.Chemotherapy: Traditional chemotherapy agents may lead to alopecia, nail changes, and mucositis. These effects are often temporary but can be distressing for patients.Immunotherapy: Agents such as checkpoint inhibitors can cause immune-related adverse events, including dermatitis and vitiligo, due to immune system activation.Radiation therapy: Patients undergoing radiation may experience radiation dermatitis, which can range from mild erythema to severe desquamation.Recognition and DiagnosisTimely recognition of CAEs is crucial for effective management. Dermatologists should maintain a high index of suspicion when treating cancer patients presenting with new skin lesions, rashes, or other dermatologic symptoms.The diagnosis of CAEs typically involves a thorough history-taking and physical examination. Key considerations include:Timing: Understanding the timeline of the patient's cancer treatment can help correlate skin changes with specific therapies.Previous treatments: Documenting prior therapies can provide insight into potential skin reactions based on known adverse events.Patient symptoms: Inquiring about associated symptoms such as itching, burning, or pain can help different